Hansa Biopharma AB - Company Profile
Powered by 
All the sales intelligence you need on Hansa Biopharma AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Hansa Biopharma AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Hansa Biopharma AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Hansa Biopharma AB’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Hansa Biopharma AB's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Peter Nicklin
Chairman Executive BoardMr. Peter Nicklin has been the Chairman of the company since 2022. Currently, he serves as the Chairman of Tunstall Healthcare, Sciensus, and Versantis. Prior to this, he served as the Chief Executive Officer and Director of Amann Girrbach AG from June 2017 to January 2020. Previosuly, he served as the Corporate Vice President and EMEA President of Baxter International. Mr. Nicklin also served in various senior executive roles at Bayer Healthcare, Bristol-Myers Squibb, and Novartis.
Renee Aguiar-Lucander
Chief Executive Officer Senior ManagementMs. Renee Aguiar-Lucander has been the Chief Executive Officer of the company since 2025. Prior to this, she served as the Chief Executive Officer of Calliditas Therapeutics AB. Previously, she worked at Omega Funds and 3i Group.
Adam Cutler
Chief Financial Officer Senior ManagementMr. Adam Cutler has been the Chief Financial Officer of the company since June 2026. Previously, he served as Chief Financial Officer of Q32 Bio. Prior to this, he was the Chief Financial Officer of Molecular Templates.
Maria Tornsen
President - US; Chief Operating Officer Senior ManagementMs. Maria Tornsen has been the Chief Operating Officer and President of the US region of the company since 2025. Prior to this, she served as the President of North America division at Calliditas Therapeutics. Previously, she served as the Chief Commercial Officer (CCO) at Passage Bio.
Hitto Kaufmann, Ph.D
Chief Scientific Officer; Chief Technology Officer Senior ManagementMr. Hitto Kaufmann has been the Chief Scientific Officer and Chief Technology Officer of the company since 2023. Prior to this, he served as the Chief Scientific Officer at Pieris Pharmaceuticals from 2019 to 2023. Previously, he served in various leadership roles at Boehringer Ingelheim.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer